| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Cue Biopharma, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | Tevogen Bio Holdings Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| Fr | Cellectar Biosciences, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| Fr | BiomX Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| Fr | Longeveron Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| Fr | CERUS CORP - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | ZyVersa Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | Decoy Therapeutics Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| Fr | Revelation Biosciences, Inc.: Revelation Biosciences Announces Adoption of Stockholder Rights Plan | 221 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / July 10, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to... ► Artikel lesen | |
| Fr | Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 2 | GlobeNewswire (USA) | ||
| Fr | Context Therapeutics Inc.: Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 2 | GlobeNewswire (USA) | ||
| Fr | Korro Bio, Inc.: Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 1 | GlobeNewswire (USA) | ||
| Fr | GeoVax Labs, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| Fr | Cadrenal Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 10.07.2026 | 459 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 10.07.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 10.07.2026.ISIN NameAU000000OPT2 OPTHEA... ► Artikel lesen | |
| Fr | Mizuho raises Nurix stock price target to $34 on Roche deal | 3 | Investing.com | ||
| Fr | Mizuho erhöht Kursziel für Nurix-Aktie nach Roche-Deal auf 34 US-Dollar | 4 | Investing.com Deutsch | ||
| Fr | Will Myqorzo Drive Cytokinetics Higher Despite Competitive Pressure? | 2 | Zacks | ||
| Fr | 3 Reasons to Buy CRISPR Therapeutics Stock | 15 | The Motley Fool | ||
| Fr | Young people living with PKU take the mic in BioMarin podcast series, TikTok push | 2 | FiercePharma |
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| NURIX THERAPEUTICS | 9 | 4 | -6,52 % | Nurix Therapeutics, Inc.: Nurix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Entered into global collaboration with Roche for bexobrutideg, with potential total payments of up to $2.3 billion, including $700 million upfront payment Co-development, co-commercialization collaboration... ► Artikel lesen | ||
| BIONTECH | 6 | 13 | -1,72 % | PRESSESPIEGEL/Unternehmen: VOLKSWAGEN, RENK, MERCEDES-BENZ, DEUTSCHE POST, BIONTECH, OPENAI, QUANTUM SYSTEMS, TRADE REPUBLIC, LOCKHEED MARTIN | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
VOLKSWAGEN - Trotz einer Verschärfung seines Sparkurses plant Europas... ► Artikel lesen | ||
| QIAGEN | 6 | 4 | -0,72 % | Dividendenbekanntmachungen (07.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABC ARBITRAGE SA FR0004040608 - 0,04 EUR ACCIONA SA ES0125220311 - 5,7486 EUR AMICA SA PLAMICA00010 2,5 PLN 0,5829 EUR ANY BIZTONSAGI... ► Artikel lesen | ||
| SILO PHARMA | 6 | 1 | -26,00 % | Silo Pharma, Inc.: Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules | $4 million upfront with up to approximately $7.7 million of potential additional gross proceeds upon the exercise in full of warrants in cash SARASOTA, FLA., July 10, 2026 (GLOBE NEWSWIRE) -- Silo... ► Artikel lesen | ||
| MESOBLAST | 5 | 3 | +0,70 % | Novo Nordisk revolutionierte Diabetes, CAR-T die Krebsmedizin - entsteht jetzt die nächste Biotech-Plattform? | |||
| EVOTEC | 4 | 44 | -0,88 % | Hensoldt äußert sich zum Rheinmetall-Debakel! Power Metallic Mines Aktie vor Kursexplosion? Was macht Evotec? | Steht bei Power Metallic Mines eine Kursexplosion kurz bevor? Analysten sehen den fairen Wert des Multi-Metall-Explorers über 150 % höher. Im aktuellen Interview hat der CEO die Ressourcenschätzung... ► Artikel lesen | ||
| CERYVYN THERAPEUTICS | 4 | 2 | 0,00 % | XFRA UKJ: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILOPTHEA LTD UKJ AU000000OPT2... ► Artikel lesen | ||
| CUE BIOPHARMA | 4 | 2 | +16,53 % | Cue Biopharma to raise $50M in oversubscribed private placement | |||
| SL SCIENCE | 4 | - | +4,39 % | SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma | Taipei, TAIWAN, July 10, 2026 (GLOBE NEWSWIRE) -- SL Science Holding Limited ("SL Science" or the "Company") (Nasdaq: SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative... ► Artikel lesen | ||
| VALNEVA | 3 | 5 | -2,97 % | SCHOCKMELDUNG bei Valneva: 3,8% Verlust und das könnte erst der Anfang sein - Handeln Sie, bevor es zu spät ist |
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| DARWIN AG | 6,800 | 24,75 | +264 % | 1 | - | - | |||
| BIO-GATE AG | 0,615 | 1,80 | +193 % | - | 1 | - | |||
| NANOREPRO AG | 2,150 | 4,50 | +109 % | 1 | - | - | |||
| EVOTEC SE | 4,946 | 8,07 | +63 % | 4 | 2 | - | |||
| BIONTECH SE ADR | 79,95 | 117,79 | +47 % | 4 | - | - | |||
| SARTORIUS STEDIM BIOTECH SA | 183,80 | 224,80 | +22 % | 6 | 1 | - | |||
| ARGENX SE | 763,60 | 853 | +12 % | 14 | 1 | - | |||
| MODERNA INC | 59,97 | 38,28 | -36 % | - | 1 | - |